Sign inJoin waitlistJoin the waitlist

Aliyah Pabani

Co-Director, Immune-Related Toxicity Team · Johns Hopkins University School of Medicine

Credentials: · · ·

History

Immune-Related Toxicity Team · Johns Hopkins University School of Medicine
Present

Hematology and Medical Oncology
2021–2024
Columbia University Irving Medical Center
2018–2021
Doctor of Medicine
2008–2012

Research

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
The Lancet Oncology · 2020 · 540 citations
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Journal of Clinical Oncology · 2019 · 206 citations
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
JAMA Network Open · 2024 · 153 citations

DH
Daniel Heng
8 papers
Julie Brahmer
4 papers
CH
Christine Hann
3 papers
Cristina Natha
3 papers · 3 as a resident
JN
Jarushka Naidoo
3 papers
JM
Joseph Murray
3 papers
NR
Naiyer Rizvi
3 papers
RS
Randeep Sangha
3 papers
RA
Rohan Ahuja
3 papers · 3 as a fellow
Yinghong Wang
3 papers
BL
Benjamin Levy
2 papers
CK
Chester Kao
2 papers

Clinical trials

Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events
Principal investigator · Not yet recruiting · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2026–2029